MedTrace Logo

Invasive Monitoring of Pulmonary Artery Pressure (PAP) Among Dialysis Treated Patients

NCT02862197 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2017-08-23

No results posted yet for this study

Summary

The purpose of this study is examine whether invasive pulmonary artery pressure (PAP) monitoring could be beneficial for the patients in dialysis treatment. Ten implantable pressure sensors (CardioMEMS ®) will be implanted and the PAPs of the individual participants are recorded during and in between the routine dialysis treatment sessions. This is an exploratory pilot study, where major interest lies in the values and changes in PAP in relation to other hemodynamic parameters among patients in dialysis treatment. Implanted device is only monitoring the patient without any effect on the actual treatment.

Conditions

Sponsors & Collaborators

  • Joint Authority for Päijät-Häme Social and Health Care

    lead OTHER

Principal Investigators

  • Tuomas V Kerola, MD PhD · Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-09-30
Completion
2017-10-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02862197 on ClinicalTrials.gov